FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

By

The FDA approval of Eli Lilly’s GLP-1 pill Foundayo comes nearly three months after Novo Nordisk’s oral version of Wegovy hit the market.

Source: Cnbc.com

Original source: https://www.cnbc.com/2026/04/01/eli-lilly-glp-1-pill-foundayo-approved-for-obesity.html

Post Views: 3

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *